Study of GC101 TIL in Brain Glioma (Soochow2)

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Lan Qing) · szlq006@163.com · +86 0512 67784089

Study leads

Qing Lan
Principal Investigator
Second Affiliated Hospital of Soochow University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Recurrent World Health Organization (WHO) Grade II Glioma · Low-grade Glioma · High Grade Glioma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Los Angeles, United States

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Childhood Astrocytoma · Childhood Diffuse Intrinsic Pontine Glioma · Childhood Diffuse Midline Glioma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Los Angeles, United States

A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors

Recurrent Glioma · Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Chongqing, China

CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults

Diffuse Midline Glioma, H3 K27M-Mutant · Recurrent High Grade Glioma

Abroad (travel likely)RecruitingPHASE1

Minneapolis, United States